Fujifilm Holdings Corp’s new chief operating officer said the Japanese technology company was still seeking mergers or acquisitions in areas such as regenerative medicine, after failing to buy the medical division of Toshiba Corp.
“There are various deals on the table, though I can’t give details,” Kenji Sukeno said in an interview on Thursday.
Fujifilm’s healthcare division grew out of a major portfolio reshuffle over the past decade which has brought the firm record profit, at a time when the market for its once-mainstay photographic film shrank dramatically.
